EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Antibiotice's enterprise value is lei1,370.2 Mil.
Antibiotice's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was lei600.8 Mil. Therefore, Antibiotice's EV-to-Revenue for today is 2.28.
The historical rank and industry rank for Antibiotice's EV-to-Revenue or its related term are showing as below:
BSE:ATB'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.86 Med: 1.33 Max: 2.28
Current: 2.28
During the past 13 years, the highest EV-to-Revenue of Antibiotice was 2.28. The lowest was 0.86. And the median was 1.33.
BSE:ATB's EV-to-Revenue is ranked better than 50.83% of 1025
companies
in the Drug Manufacturers industry
Industry Median: 2.32
vs BSE:ATB: 2.28
As of today (2024-04-30), Antibiotice's stock price is lei1.945.
Antibiotice's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was lei0.89. Therefore, Antibiotice's PS Ratio for today is 2.18.
Antibiotice EV-to-Revenue Historical Data
The historical data trend for Antibiotice's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Antibiotice's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Antibiotice's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Antibiotice's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Antibiotice's EV-to-Revenue falls into.
Antibiotice's current Enterprise Value is lei1,370.2 Mil.
Antibiotice's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was lei600.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Antibiotice's share price for today is lei1.945.
Antibiotice's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was lei0.89.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Antibiotice EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Antibiotice's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSE:ATB has been successfully added to your 